Kindstar Globalgene Technology, Inc. (HKG:9960)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.150
0.00 (0.00%)
Mar 10, 2026, 9:31 AM HKT
-11.54%
Market Cap 1.15B
Revenue (ttm) 998.42M
Net Income (ttm) -112.38M
Shares Out 996.57M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend 0.02 (2.05%)
Ex-Dividend Date Jun 9, 2025
Volume 5,000
Average Volume 393,450
Open 1.150
Previous Close 1.150
Day's Range 1.130 - 1.150
52-Week Range 1.030 - 1.750
Beta 0.70
RSI 40.02
Earnings Date Mar 27, 2026

About HKG:9960

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, m... [Read more]

Sector Healthcare
Founded 2003
Employees 3,162
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9960
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.